Drug
Remifentanil 2 MG
Remifentanil 2 MG is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
50%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (50.0%)
N/A2 (50.0%)
Trials by Status
unknown125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Minimal Flow Anesthesia and Infection Risk
NCT07092046
completednot_applicable
Effects Of Anaesthesia on Intraocular Pressure in Robotic Prostate Surgery
NCT07033442
completedphase_4
Comparison of the Effects of Remifentanil and Dexmedetomidine Administered Under General Anesthesia in Rhinoplasty
NCT05572723
unknownphase_4
Effects of Remifentanil on Cardiac Function in Patients With Diastolic Dysfunction
NCT04117009
Clinical Trials (4)
Showing 4 of 4 trials
NCT07092046Not Applicable
Minimal Flow Anesthesia and Infection Risk
NCT07033442Not Applicable
Effects Of Anaesthesia on Intraocular Pressure in Robotic Prostate Surgery
NCT05572723Phase 4
Comparison of the Effects of Remifentanil and Dexmedetomidine Administered Under General Anesthesia in Rhinoplasty
NCT04117009Phase 4
Effects of Remifentanil on Cardiac Function in Patients With Diastolic Dysfunction
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4